Search Results - "Bonifazi, Francesca"
-
1
Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel
Published in Bone marrow transplantation (Basingstoke) (01-06-2020)“…This collaborative initiative aimed to provide recommendations on the use of polyclonal antithymocyte globulin (ATG) or anti-T lymphocyte globulin (ATLG) for…”
Get full text
Journal Article -
2
Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation
Published in Blood (12-09-2019)“…The use of anti-thymocyte globulin (ATG) has represented the standard of care in graft-versus-host disease (GVHD) prophylaxis in patients undergoing a…”
Get full text
Journal Article -
3
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation
Published in Frontiers in immunology (03-04-2020)“…Hepatic veno-occlusive disease (VOD) or sinusoidal obstruction syndrome (SOS) is a rare complication characterized by hepatomegaly, right-upper quadrant pain,…”
Get full text
Journal Article -
4
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease
Published in The New England journal of medicine (07-01-2016)“…Antilymphocyte globulin (ATG) added to the conditioning regimen before allogeneic hematopoietic stem-cell transplantation resulted in a lower rate of chronic…”
Get full text
Journal Article -
5
The complexity of stem cell transplants: can we improve our understanding?
Published in Haematologica (Roma) (01-09-2018)Get full text
Journal Article -
6
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia
Published in Leukemia (01-05-2022)“…In this provocative commentary, we consider several questions posed by the late chronic myeloid leukaemia (CML) expert Prof. Michele Baccarani, which he…”
Get full text
Journal Article -
7
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies
Published in Clinical transplantation (01-10-2019)“…Cytomegalovirus (CMV) remains a major cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation (allo‐HSCT) and solid organ…”
Get full text
Journal Article -
8
Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity
Published in Journal of neurology (01-02-2022)“…Chimeric antigen receptor (CAR) T-cell therapy is an emerging highly effective treatment for refractory haematological malignancies. Unfortunately, its…”
Get full text
Journal Article -
9
Meibomian Gland Dropout in Hematological Patients Before Hematopoietic Stem Cell Transplantation
Published in Cornea (01-10-2018)“…PURPOSE:To perform qualitative and quantitative analysis of meibomian gland (MG) dropout in hematological patients before hematopoietic stem cell…”
Get full text
Journal Article -
10
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Published in BMC health services research (22-01-2024)“…Chimeric antigen receptor T cells (CAR-T) represent an innovation but raise issues for healthcare payers because of the uncertainty on impact at market launch,…”
Get full text
Journal Article -
11
Epigenetic age acceleration in hematopoietic stem cell transplantation
Published in Haematologica (Roma) (03-10-2024)“…Not available.Not available…”
Get full text
Journal Article -
12
Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
Published in Bone marrow transplantation (Basingstoke) (01-04-2020)“…In many healthcare settings, benchmarking for complex procedures has become a mandatory requirement by competent authorities, regulators, payers and patients…”
Get full text
Journal Article Web Resource -
13
-
14
Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody—Begelomab
Published in Bone marrow transplantation (Basingstoke) (01-08-2020)“…We have treated 69 patients with steroid refractory acute graft versus host disease (SR-aGvHD), with an anti-CD26 monoclonal antibody (Begelomab): 28 patients…”
Get full text
Journal Article -
15
Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome
Published in Frontiers in immunology (12-03-2021)Get full text
Journal Article -
16
-
17
Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience
Published in Haematologica (Roma) (01-06-2023)Get full text
Journal Article -
18
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)
Published in Bone marrow transplantation (Basingstoke) (01-09-2021)“…The Transplant Centers belonging to Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO) conducted a survey with the aim of evaluating the effect of…”
Get full text
Journal Article -
19
Pleuroparenchymal fibroelastosis: the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipients
Published in Diagnostic and interventional radiology (Ankara, Turkey) (01-09-2016)“…Pleuroparenchymal fibroelastosis (PPFE) is a rare form of interstitial pneumonia, characterized by elastotic fibrosis involving the pleura and subpleural…”
Get full text
Journal Article -
20
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas
Published in Bone marrow transplantation (Basingstoke) (01-09-2021)Get full text
Journal Article